Defining "success" in recruitment of underrepresented populations to cancer clinical trials: Moving toward a more consistent approach

Shari Bolen, Jon C Tilburt, Charlie Baffi, Tiffany L. Gary, Neil Powe, Mollie Howerton, Jean Ford, Gabriel Lai, Renee Wilson, Eric Bass

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Although medically underserved groups bear a heavy burden of cancer disease and governmental agencies have required inclusion of minorities and women in cancer clinical trials since 1993, many of these groups are underrepresented in cancer prevention or treatment clinical trials. To assess and enhance recruitment of underrepresented populations into cancer-related clinical trials, investigators and governmental agencies need consistent measurement approaches for recruitment that can be applied to diverse settings where trials are conducted. We conducted a systematic review to evaluate what measurement approaches were used to evaluate the success of recruitment of underrepresented groups into cancer prevention or treatment trials, and whether these recruitment goals were stated a priori. Only two articles reported an a priori recruitment goal. The recruitment measurement approaches varied considerably, with no consistent standard, especially for individual trials. By using the empiric evidence from this review in conjunction with the National Institutes of Health (NIH) guidelines, we constructed a framework for choosing consistent a priori recruitment goals for underrepresented groups based on the research question and study location. Using consistent measurement approaches for underrepresented groups will improve comparability of recruitment strategies across trials, improve equity in distribution of benefits and burdens of cancer-related clinical trials, and may improve applicability of trial results to multiple populations.

Original languageEnglish (US)
Pages (from-to)1197-1204
Number of pages8
JournalCancer
Volume106
Issue number6
DOIs
StatePublished - Mar 15 2006
Externally publishedYes

Fingerprint

Clinical Trials
Population
Neoplasms
National Institutes of Health (U.S.)
Research Personnel
Guidelines
Therapeutics
Research

Keywords

  • Accrual
  • Cancer
  • Clinical trials
  • Minority
  • Recruitment
  • Underrepresented
  • Underserved

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Defining "success" in recruitment of underrepresented populations to cancer clinical trials : Moving toward a more consistent approach. / Bolen, Shari; Tilburt, Jon C; Baffi, Charlie; Gary, Tiffany L.; Powe, Neil; Howerton, Mollie; Ford, Jean; Lai, Gabriel; Wilson, Renee; Bass, Eric.

In: Cancer, Vol. 106, No. 6, 15.03.2006, p. 1197-1204.

Research output: Contribution to journalArticle

Bolen, S, Tilburt, JC, Baffi, C, Gary, TL, Powe, N, Howerton, M, Ford, J, Lai, G, Wilson, R & Bass, E 2006, 'Defining "success" in recruitment of underrepresented populations to cancer clinical trials: Moving toward a more consistent approach', Cancer, vol. 106, no. 6, pp. 1197-1204. https://doi.org/10.1002/cncr.21745
Bolen, Shari ; Tilburt, Jon C ; Baffi, Charlie ; Gary, Tiffany L. ; Powe, Neil ; Howerton, Mollie ; Ford, Jean ; Lai, Gabriel ; Wilson, Renee ; Bass, Eric. / Defining "success" in recruitment of underrepresented populations to cancer clinical trials : Moving toward a more consistent approach. In: Cancer. 2006 ; Vol. 106, No. 6. pp. 1197-1204.
@article{850cfe10795d44a58d8f6113cb0e43cb,
title = "Defining {"}success{"} in recruitment of underrepresented populations to cancer clinical trials: Moving toward a more consistent approach",
abstract = "Although medically underserved groups bear a heavy burden of cancer disease and governmental agencies have required inclusion of minorities and women in cancer clinical trials since 1993, many of these groups are underrepresented in cancer prevention or treatment clinical trials. To assess and enhance recruitment of underrepresented populations into cancer-related clinical trials, investigators and governmental agencies need consistent measurement approaches for recruitment that can be applied to diverse settings where trials are conducted. We conducted a systematic review to evaluate what measurement approaches were used to evaluate the success of recruitment of underrepresented groups into cancer prevention or treatment trials, and whether these recruitment goals were stated a priori. Only two articles reported an a priori recruitment goal. The recruitment measurement approaches varied considerably, with no consistent standard, especially for individual trials. By using the empiric evidence from this review in conjunction with the National Institutes of Health (NIH) guidelines, we constructed a framework for choosing consistent a priori recruitment goals for underrepresented groups based on the research question and study location. Using consistent measurement approaches for underrepresented groups will improve comparability of recruitment strategies across trials, improve equity in distribution of benefits and burdens of cancer-related clinical trials, and may improve applicability of trial results to multiple populations.",
keywords = "Accrual, Cancer, Clinical trials, Minority, Recruitment, Underrepresented, Underserved",
author = "Shari Bolen and Tilburt, {Jon C} and Charlie Baffi and Gary, {Tiffany L.} and Neil Powe and Mollie Howerton and Jean Ford and Gabriel Lai and Renee Wilson and Eric Bass",
year = "2006",
month = "3",
day = "15",
doi = "10.1002/cncr.21745",
language = "English (US)",
volume = "106",
pages = "1197--1204",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Defining "success" in recruitment of underrepresented populations to cancer clinical trials

T2 - Moving toward a more consistent approach

AU - Bolen, Shari

AU - Tilburt, Jon C

AU - Baffi, Charlie

AU - Gary, Tiffany L.

AU - Powe, Neil

AU - Howerton, Mollie

AU - Ford, Jean

AU - Lai, Gabriel

AU - Wilson, Renee

AU - Bass, Eric

PY - 2006/3/15

Y1 - 2006/3/15

N2 - Although medically underserved groups bear a heavy burden of cancer disease and governmental agencies have required inclusion of minorities and women in cancer clinical trials since 1993, many of these groups are underrepresented in cancer prevention or treatment clinical trials. To assess and enhance recruitment of underrepresented populations into cancer-related clinical trials, investigators and governmental agencies need consistent measurement approaches for recruitment that can be applied to diverse settings where trials are conducted. We conducted a systematic review to evaluate what measurement approaches were used to evaluate the success of recruitment of underrepresented groups into cancer prevention or treatment trials, and whether these recruitment goals were stated a priori. Only two articles reported an a priori recruitment goal. The recruitment measurement approaches varied considerably, with no consistent standard, especially for individual trials. By using the empiric evidence from this review in conjunction with the National Institutes of Health (NIH) guidelines, we constructed a framework for choosing consistent a priori recruitment goals for underrepresented groups based on the research question and study location. Using consistent measurement approaches for underrepresented groups will improve comparability of recruitment strategies across trials, improve equity in distribution of benefits and burdens of cancer-related clinical trials, and may improve applicability of trial results to multiple populations.

AB - Although medically underserved groups bear a heavy burden of cancer disease and governmental agencies have required inclusion of minorities and women in cancer clinical trials since 1993, many of these groups are underrepresented in cancer prevention or treatment clinical trials. To assess and enhance recruitment of underrepresented populations into cancer-related clinical trials, investigators and governmental agencies need consistent measurement approaches for recruitment that can be applied to diverse settings where trials are conducted. We conducted a systematic review to evaluate what measurement approaches were used to evaluate the success of recruitment of underrepresented groups into cancer prevention or treatment trials, and whether these recruitment goals were stated a priori. Only two articles reported an a priori recruitment goal. The recruitment measurement approaches varied considerably, with no consistent standard, especially for individual trials. By using the empiric evidence from this review in conjunction with the National Institutes of Health (NIH) guidelines, we constructed a framework for choosing consistent a priori recruitment goals for underrepresented groups based on the research question and study location. Using consistent measurement approaches for underrepresented groups will improve comparability of recruitment strategies across trials, improve equity in distribution of benefits and burdens of cancer-related clinical trials, and may improve applicability of trial results to multiple populations.

KW - Accrual

KW - Cancer

KW - Clinical trials

KW - Minority

KW - Recruitment

KW - Underrepresented

KW - Underserved

UR - http://www.scopus.com/inward/record.url?scp=33644845395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644845395&partnerID=8YFLogxK

U2 - 10.1002/cncr.21745

DO - 10.1002/cncr.21745

M3 - Article

C2 - 16453333

AN - SCOPUS:33644845395

VL - 106

SP - 1197

EP - 1204

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 6

ER -